Spanish drugmaker Grifols says Brookfield’s potential €6.45-billion offer undervalues the company

📆 19.11.2024 16:53:00
📰 globeandmail

⏱ Reading Time:
10 sec. here
2 min. at publisher
📊 Quality Score:
News: 7%
Publisher: 92%

Streetwise Новости

Россия Последние новости,Россия Последние новости

Earlier on Tuesday, Brookfield said it was considering a public offer for Grifols at €10.50 per A share and €7.62 per B share, implying a company valuation of €6.45-billion

potential €6.45-billion offer significantly undervalued the Spanish drugmaker’s prospects and long-term potential.

Grifols said its board would meet later on Tuesday to consider the potential offer, but that, given the valuation, it would not be in a position to recommend that shareholders accept it.

Написать комментарий

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

Россия Последние новости, Россия Последние новости